Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.74 |
| ▸ | CASP2 | P42575 | 1/20 | 0.57 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.56 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.56 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.56 |
| ▸ | FAAH | O00519 | 4/20 | 0.55 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.54 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31734852 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL31358862 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL15986104 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL31711351 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL13855547 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL17392871 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL1243678 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL358468 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL2386271 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 | |
| SCHEMBL20162089 | 1.00 | NOD1 (0.74) | NOD1CASP2GNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302732-A1 | BIOBASED, BIODEGRADABLE COMPOSITE POWDER FOR USE IN COSMETICS | GRANT INDUSTRIES, INC. (US) | 2025-10-02 | — | — | US | claimed |
| US-12337059-B2 | Biobased, biodegradable composite powder for use in cosmetics | GRANT INDUSTRIES, INC. (US) | 2025-06-24 | — | — | US | claimed |
| WO-2025128224-A1 | A COMPOSITON FOR ANTI-CAKING AND/OR MOISTURE REDUCTION FOR FERTILIZERS COMPRISED OF AN AMINO ACID ALK(EN)YL (ARYL) DERIVATIVE | ArrMaz Products Inc. (US) | 2025-06-19 | — | — | WO | claimed |
| CN-114652655-B | Waterproof sweat-resistant, anti-aging and repair-type sun-screening composition and preparation method thereof | 上海康美国际生化有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-118388363-A | High-purity lauroyl lysine and preparation method thereof | 广州经久生物科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| EP-4357403-A1 | COMPOSITION AND METHOD FOR PRODUCING SAME | Daicel Corporation (JP) | 2024-04-24 | — | — | EP | claimed |
| CN-116640582-A | Mild amino acid facial cleanser and preparation method thereof | 广州夏刚科技有限公司 | 2023-08-25 | — | — | CN | claimed |
| EP-4213802-A1 | BIOBASED, BIODEGRADABLE COMPOSITE POWDER FOR USE IN COSMETICS | Grant Industries, Inc. (US) | 2023-07-26 | — | — | EP | claimed |
| CN-116437895-A | Bio-based biodegradable composite powder for cosmetics | 格兰特工业公司 | 2023-07-14 | — | — | CN | claimed |
| WO-2022264693-A1 | COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2022-12-22 | — | — | WO | claimed |
| EP-2825180-A1 | TREATED PLATY SUBSTRATES | BASF Corporation (US) | 2015-01-21 | — | — | EP | claimed |
| US-20130259914-A1 | TREATED PLATY SUBSTRATES | COLORS & EFFECTS USA LLC | 2013-10-03 | — | — | US | claimed |
| WO-2013138312-A1 | TREATED PLATY SUBSTRATES | BASF CORPORATION (US) | 2013-09-19 | — | — | WO | claimed |
| EP-1852502-B1 | N -ACYL-L-LYSINE-SPECIFIC AMINOACYLASE | AJINOMOTO KK (JP) | 2012-04-18 | — | — | EP | claimed |
| US-7888079-B2 | microbial N epsilon -acyl-L-lysine-specific degrading and synthesizing enzyme to release a carboxylic acid and L-lysine | AJINOMOTO CO., INC. (JP) | 2011-02-15 | — | — | US | claimed |
| US-20070298469-A1 | N-EPSILON-ACYL-L-LYSINE-SPECIFIC AMINOACYLASE | AJINOMOTO CO., INC. (JP) | 2007-12-27 | — | — | US | claimed |
| EP-1852502-A1 | N -ACYL-L-LYSINE-SPECIFIC AMINOACYLASE | Ajinomoto Co., Inc. (JP) | 2007-11-07 | — | — | EP | claimed |
| EP-0489657-B1 | Improved platy pigments | MEARL CORP (US) | 1995-08-02 | — | — | EP | claimed |
| US-5326392-A | Platy pigments | THE MEARL CORPORATION (US) | 1994-07-05 | — | — | US | claimed |
| EP-0489657-A1 | Improved platy pigments | THE MEARL CORPORATION (US) | 1992-06-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130259914-A1 | TREATED PLATY SUBSTRATES | CUTA, MICA, PLAT | NOD1 4792/4885CASP2 3675/4885GNAI3 4801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.